Business

ERMA: Net sales rose sharply and losses narrowed as US pouch sales accelerated

ERMA: Net sales rose sharply and losses narrowed as US pouch sales accelerated

Enorama Pharma AbNovember 20, 20244
ERMA: Net sales rose sharply and losses narrowed as US pouch sales accelerated

About this update from Enorama Pharma Ab

Net sales surged year-over-year, driven by US pouch sales, while operating losses narrowed. Production was stabilized at Habit Factory, new partnerships were formed, and capital was raised to support growth. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Enorama Pharma Ab